ARGUMENTS FOR A CHANGE IN PRACTICE - Single antiplatelet therapy in combination with reduced oral anticoagulation reduces the rate of bleeding events in comparison to triple therapy after PCI in patients with atrial fibrillation (PIONEER AF-PCI, WOEST). ARGUMENTS AGAINST A CHANGE IN PRACTICE - Current trials are underpowered to assess the risk of ischaemic events adequately, especially stent thrombosis. - Differences in bleeding events are mainly driven by minor bleedings. - Patients must be responders to the agent used in case of single antiplatelet therapy in combination with oral anticoagulation. Results of further ongoing trials (REDUAL-PCI, ENTRUSTAF-PCI, AUGUSTUS) are expected soon.

Will PIONEER AF-PCI change my practice?

Leonardi S.;
2017-01-01

Abstract

ARGUMENTS FOR A CHANGE IN PRACTICE - Single antiplatelet therapy in combination with reduced oral anticoagulation reduces the rate of bleeding events in comparison to triple therapy after PCI in patients with atrial fibrillation (PIONEER AF-PCI, WOEST). ARGUMENTS AGAINST A CHANGE IN PRACTICE - Current trials are underpowered to assess the risk of ischaemic events adequately, especially stent thrombosis. - Differences in bleeding events are mainly driven by minor bleedings. - Patients must be responders to the agent used in case of single antiplatelet therapy in combination with oral anticoagulation. Results of further ongoing trials (REDUAL-PCI, ENTRUSTAF-PCI, AUGUSTUS) are expected soon.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/1341956
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact